dihexa degradation pathways tyrosine oxidation pathway showing tyrosine catabolism and pyomelanin Tyrosinase drives hydroquinone-induced exogenous ochronosis:
Description
Much more research is needed
Published online July 31, 2025
The brain microenvironment induces DNMT1 suppression and indolence of metastatic cancer cells
AstraZeneca Lead assets: Elecoglipron, an oral GLP-1RA candidate Metabolic focus: Obesity, overweight, type 2 diabetes and cardiometabolic disease AstraZeneca is developing elecoglipron as a once-daily GLP-1RA pill for obesity and type 2 diabetes
High proline content, acid-stable
